DRISDOL Drug Patent Profile
✉ Email this page to a colleague
When do Drisdol patents expire, and when can generic versions of Drisdol launch?
Drisdol is a drug marketed by Ss Pharma and is included in one NDA.
The generic ingredient in DRISDOL is ergocalciferol. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Drisdol
A generic version of DRISDOL was approved as ergocalciferol by CHARTWELL RX on May 20th, 2009.
Summary for DRISDOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,434 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in DRISDOL? | DRISDOL excipients list |
| DailyMed Link: | DRISDOL at DailyMed |
Recent Clinical Trials for DRISDOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wake Forest University Health Sciences | Early Phase 1 |
| Albany College of Pharmacy and Health Sciences | Phase 4 |
| Hortense & Louis Rubin Dialysis Center | Phase 4 |
Pharmacology for DRISDOL
| Drug Class | Provitamin D2 Compound |
Anatomical Therapeutic Chemical (ATC) Classes for DRISDOL
US Patents and Regulatory Information for DRISDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ss Pharma | DRISDOL | ergocalciferol | CAPSULE;ORAL | 003444-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
